GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » PS Ratio

Qyuns Therapeutics Co (HKSE:02509) PS Ratio : (As of Mar. 26, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Qyuns Therapeutics Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Qyuns Therapeutics Co's share price is HK$8.60. Qyuns Therapeutics Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.00. Hence, Qyuns Therapeutics Co's PS Ratio for today is .

The historical rank and industry rank for Qyuns Therapeutics Co's PS Ratio or its related term are showing as below:

HKSE:02509's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 8.475
* Ranked among companies with meaningful PS Ratio only.

Qyuns Therapeutics Co's Revenue per Sharefor the three months ended in Jun. 2024 was HK$0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.00.

Back to Basics: PS Ratio


Qyuns Therapeutics Co PS Ratio Historical Data

The historical data trend for Qyuns Therapeutics Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qyuns Therapeutics Co PS Ratio Chart

Qyuns Therapeutics Co Annual Data
Trend Dec21 Dec22 Dec23
PS Ratio
- - -

Qyuns Therapeutics Co Quarterly Data
Dec21 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24
PS Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of Qyuns Therapeutics Co's PS Ratio

For the Biotechnology subindustry, Qyuns Therapeutics Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qyuns Therapeutics Co's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Qyuns Therapeutics Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Qyuns Therapeutics Co's PS Ratio falls into.


';

Qyuns Therapeutics Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Qyuns Therapeutics Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=8.60/0
=

Qyuns Therapeutics Co's Share Price of today is HK$8.60.
Qyuns Therapeutics Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Qyuns Therapeutics Co  (HKSE:02509) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Qyuns Therapeutics Co PS Ratio Related Terms

Thank you for viewing the detailed overview of Qyuns Therapeutics Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Qyuns Therapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN
Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline.
Executives
Zhu Jing
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership)
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Qing Dao Xin Chen Ke Chuang Shi Ye You Xian Gong Si
Zi Jin Xin Tuo You Xian Ze Ren Gong Si
Tai Zhou Hua Cheng Yi Xue Tou Zi Ji Tuan You Xian Gong Si
Nan Jing Zi Jin Tou Zi Ji Tuan You Xian Ze Ren Gong Si
Nan Jing Shi Guo You Zi Chan Tou Zi Guan Li Kong Gu Ji Tuan You Xian Ze Ren Gong Si
Bei Jing Hong Tai Tong Chuang Tou Zi Guan Li You Xian Gong Si
Sheng Xi Tai
Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Hu Kaijun 2201 Interest of corporation controlled by you
Yu Guo'an
Hangzhou Quanyi Investment Management Partnership (general Partnership)

Qyuns Therapeutics Co Headlines

No Headlines